CSL Seqirus Finalises Exclusive License Agreement With Arcturus' MRNA Technology

CSL Ltd. (CSL, CSLLY,CSL.AX,CMXHF.PK) Monday announced that its subsidiary CSL Seqirus finalized a global collaboration and license agreement with Arcturus Therapeutics Holdings Inc (ARCT).

As per the agreement, CSL will have the exclusive license to Arcturus' next-generation mRNA technology in the fields of influenza, COVID-19 and other respiratory viral diseases. Further, CSL will get a non-exclusive license in the multi-pathogen pandemic preparedness field with the right to turn exclusive.

Arcturus Therapeutics will receive an upfront payment of $200 million as well as development and commercial milestone payments.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT